A Patient with neurofibromatosis type 1 and Charcot–Marie–Tooth disease type 1B

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Muscle and Nerve

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/mus.21546PMID 19918771PMCID PMC2847649
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical features and molecular modelling of novel MPZ mutations in demyelinating and axonal neuropathies

  2009cited by this paper
• Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1.

  2009cited by this paper
• Neurofibromatosis Type 1 Revisited

  2009cited by this paper
• How does the Schwann cell lineage form tumors in NF1?

  2008cited by this paper
• Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells.

  2008cited by this paper
• Mutation frequency for Charcot-Marie-Tooth disease type 1 in the Chinese population is similar to that in the global ethnic patients

  2006cited by this paper
• Reliability and validity of the CMT neuropathy score as a measure of disability

  2005cited by this paper
• Phenotypic clustering in MPZ mutations.

  2004cited by this paper
• Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey.

  2004cited by this paper
• Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot‐Marie‐Tooth neuropathy patients

  2004cited by this paper
• Neurofibromatous neuropathy in neurofibromatosis 1 (NF1)

  2004cited by this paper
• The congenital and limb-girdle muscular dystrophies: sharpening the focus, blurring the boundaries.

  2004cited by this paper
• Neurofibromas in NF1: Schwann Cell Origin and Role of Tumor Environment

  2002cited by this paper
• Regulation of Schwann cell proliferation and apoptosis in PMP22-deficient mice and mouse models of Charcot-Marie-Tooth disease type 1A.

  2001cited by this paper
• Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects

  2000influential reference
• Neurological complications of neurofibromatosis type 1 in adulthood.

  1999cited by this paper
• Loss of NF1 allele in schwann cells but not in fibroblasts derived from an NF1‐associated neurofibroma

  1999influential reference
• Regulation of Schwann cell numbers in tellurium-induced neuropathy: apoptosis, supernumerary cells and internodal shortening

  1998cited by this paper
• Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot-Marie-Tooth disease and hereditary neuropathy with liability to pressure palsies

  1997cited by this paper
• Heterozygous P0 knockout mice develop a peripheral neuropathy that resembles chronic inflammatory demyelinating polyneuropathy (CIDP).

  1997cited by this paper
• Functional abnormalities in P0‐deficient mice resemble human hereditary neuropathies linked to P0 gene mutations

  1996cited by this paper
• Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes.

  1995cited by this paper
• Protein zero (P0)–deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies

  1995cited by this paper
• Differences in proliferation and invasion by normal, transformed and NF1 Schwann cell cultures are influenced by matrix metalloproteinase expression

  1995cited by this paper
• In vivo proliferative pattern of trembler hypomyelinating Schwann cells is modified in culture: an experimental analysis.

  1993cited by this paper
• Stable inheritance of the CMT1A DNA duplication in two patients with CMT1 and NF1.

  1993influential reference
• Schwann cell proliferation during postnatal development, Wallerian degeneration and axon regeneration in trembler dysmyelinating mutant.

  1991cited by this paper
• Schwann cell proliferation following lysolecithin-induced demyelination

  1990cited by this paper
• Neurofibromatous neuropathy

  1990cited by this paper
• Angiogenic and invasive properties of neurofibroma Schwann cells

  1990cited by this paper
• Neurofibromatosis, Charcot-Marie-Tooth disease, or both?

  1989cited by this paper
• SCHWANN CELL MULTIPLICATION IN TREMBLER MICE

  1981cited by this paper
• Peripheral neurofibromatosis and peroneal muscular atrophy

  1981cited by this paper

• Nerve Enlargement in Patients with INF2 Variants Causing Peripheral Neuropathy and Focal Segmental Glomerulosclerosis

  2025cites this paper
• Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1

  2020cites this paper
• Charcot-Marie-Tooth Disease Showing diffuse Plexiform Neurofibroma - A Case Report -

  2014cites this paper
• Charcot-Marie-Tooth syndrome and neurofibromatosis type 1 with multiple neurofibromas of the entire spinal nerve roots

  2013cites this paper
• Genetic, epigenetic and functional analysis of tumorigenesis in neurofibromatosis type 1 (NF1)

  2011cites this paper